489 related articles for article (PubMed ID: 22301049)
1. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic hotline. Infliximab for treatment of resistant pyoderma gangrenosum associated with ulcerative colitis and psoriasis. A case report.
Baglieri F; Scuderi G
Dermatol Ther; 2010; 23(5):541-3. PubMed ID: 20868408
[TBL] [Abstract][Full Text] [Related]
3. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
[TBL] [Abstract][Full Text] [Related]
5. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
[No Abstract] [Full Text] [Related]
6. A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: infliximab and surgery.
Andrisani G; Guidi L; Papa A; Potenza AE; Cervelli D; Armuzzi A
J Crohns Colitis; 2013 Jun; 7(5):421-6. PubMed ID: 22889645
[TBL] [Abstract][Full Text] [Related]
7. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.
López San Román A; Bermejo F; Aldanondo I; Carrera E; Boixeda D; Muñoz Zato E
Rev Esp Enferm Dig; 2004 Jun; 96(6):420-2; 422-4. PubMed ID: 15230672
[TBL] [Abstract][Full Text] [Related]
8. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
[TBL] [Abstract][Full Text] [Related]
9. Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis.
Teich N; Klugmann T
J Crohns Colitis; 2014 Jan; 8(1):85-6. PubMed ID: 23810275
[No Abstract] [Full Text] [Related]
10. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
Dini V; Romanelli M; Bertone M; Talarico S; Bombardieri S; Barachini P
Int J Low Extrem Wounds; 2007 Jun; 6(2):108-13. PubMed ID: 17558009
[TBL] [Abstract][Full Text] [Related]
11. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of pyoderma gangrenosum and Sweet's syndrome in a patient with ulcerative colitis.
Castro-Fernández M; Sánchez-Muñoz D; Ruíz-Granados E; Merchante N; Corzo J
Am J Gastroenterol; 2007 Dec; 102(12):2865-6. PubMed ID: 18042124
[No Abstract] [Full Text] [Related]
13. Pyoderma gangrenosum and ulcerative colitis in the tropics.
Alese OB; Irabor DO
Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
[TBL] [Abstract][Full Text] [Related]
14. [Ulcerative colitis associated with pyoderma gangrenosum].
Tusnádi A; Uhrin K; Bényei M; Krasznai G
Orv Hetil; 1994 Apr; 135(17):917-9. PubMed ID: 7909938
[TBL] [Abstract][Full Text] [Related]
15. [Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis].
Lorincz M; Kleszky M; Szalóki T; Szalóki T
Orv Hetil; 2010 Jan; 151(4):144-7. PubMed ID: 20071320
[TBL] [Abstract][Full Text] [Related]
16. Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab.
Marzano AV; Tourlaki A; Alessi E; Caputo R
Clin Exp Dermatol; 2008 Mar; 33(2):156-9. PubMed ID: 18021268
[TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
18. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine.
Futami H; Kodaira M; Furuta T; Hanai H; Kaneko E
J Gastroenterol; 1998 Jun; 33(3):408-11. PubMed ID: 9658322
[TBL] [Abstract][Full Text] [Related]
19. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
[No Abstract] [Full Text] [Related]
20. A case of refractory pyoderma gangrenosum treated with a combination of Apligraf and systemic immunosuppressive agents.
Duchini G; Itin P; Arnold A
Adv Skin Wound Care; 2011 May; 24(5):217-20. PubMed ID: 21505282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
